These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18187667)
1. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice. Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):448-54. PubMed ID: 18187667 [TBL] [Abstract][Full Text] [Related]
2. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Brunham LR; Kruit JK; Pape TD; Parks JS; Kuipers F; Hayden MR Circ Res; 2006 Sep; 99(7):672-4. PubMed ID: 16946132 [TBL] [Abstract][Full Text] [Related]
3. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression. Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219 [TBL] [Abstract][Full Text] [Related]
4. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. Miao B; Zondlo S; Gibbs S; Cromley D; Hosagrahara VP; Kirchgessner TG; Billheimer J; Mukherjee R J Lipid Res; 2004 Aug; 45(8):1410-7. PubMed ID: 15145986 [TBL] [Abstract][Full Text] [Related]
5. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice. Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096 [TBL] [Abstract][Full Text] [Related]
6. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210 [TBL] [Abstract][Full Text] [Related]
7. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1. Stukas S; May S; Wilkinson A; Chan J; Donkin J; Wellington CL Biochim Biophys Acta; 2012 Mar; 1821(3):536-46. PubMed ID: 21889608 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol. Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067 [TBL] [Abstract][Full Text] [Related]
9. Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Xie Y; Kennedy S; Sidhu R; Luo J; Ory DS; Davidson NO Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1624-31. PubMed ID: 22580900 [TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291 [TBL] [Abstract][Full Text] [Related]
11. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131 [TBL] [Abstract][Full Text] [Related]
12. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. de Vogel-van den Bosch HM; de Wit NJ; Hooiveld GJ; Vermeulen H; van der Veen JN; Houten SM; Kuipers F; Müller M; van der Meer R Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1171-80. PubMed ID: 18356535 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197 [TBL] [Abstract][Full Text] [Related]
14. Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein. Murthy S; Born E; Mathur SN; Field FJ Biochem J; 2004 Feb; 377(Pt 3):545-52. PubMed ID: 14604434 [TBL] [Abstract][Full Text] [Related]
15. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. van der Veen JN; Kruit JK; Havinga R; Baller JF; Chimini G; Lestavel S; Staels B; Groot PH; Groen AK; Kuipers F J Lipid Res; 2005 Mar; 46(3):526-34. PubMed ID: 15604518 [TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Duval C; Touche V; Tailleux A; Fruchart JC; Fievet C; Clavey V; Staels B; Lestavel S Biochem Biophys Res Commun; 2006 Feb; 340(4):1259-63. PubMed ID: 16414355 [TBL] [Abstract][Full Text] [Related]
17. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577 [TBL] [Abstract][Full Text] [Related]
18. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile. Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358 [TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression. Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587 [TBL] [Abstract][Full Text] [Related]
20. TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. Field FJ; Watt K; Mathur SN J Lipid Res; 2010 Jun; 51(6):1407-15. PubMed ID: 20103810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]